Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 30 Breast Neoplasms 19 Neoplasms 13 Prostatic Neoplasms 10 Obesity 6 Colorectal Neoplasms 6 Sarcopenia 5 Pancreatic Neoplasms 5 Lung Neoplasms 4 Signs and Symptoms 3 Polycystic Ovary Syndrome 3 Multiple Myeloma 3 Lymphedema 3 Inflammation 3 Head and Neck Neoplasms 3 Fatigue 3 Diabetes Mellitus, Type 2 3 Colonic Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Osteoporosis, Postmenopausal 2 Osteoporosis 2 Lymphoma 2 Leukemia 2 Diabetes Mellitus 2 Carcinoma, Non-Small-Cell Lung 2 Cachexia 2 Weight Loss 1 Uterine Neoplasms 1 Urinary Incontinence 1

Interventions

fludarabine phosphate 15 Cyclophosphamide 15 Peripheral Blood Stem Cell Transplantation 13 Cyclosporine 12 Whole-Body Irradiation 10 Filgrastim 10 Mycophenolic Acid 9 Busulfan 8 Antilymphocyte Serum 7 Radiotherapy 5 Methylprednisolone 5 Melphalan 5 Therapeutics 4 Psychiatric Rehabilitation 4 Methotrexate 4 Exercise 4 Etoposide 4 Cord Blood Stem Cell Transplantation 4 Blood Specimen Collection 4 fludarabine 3 Rituximab 3 Prednisone 3 Granulocyte Colony-Stimulating Factor 3 Dexamethasone 3 Aprepitant 3 Analgesia 3 plerixafor 2 Tacrolimus 2 Standard of Care 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, Follicular × Resistance Training × Clear all

NCT04902092 2023-10-23

BEAT

Monash University

Phase NA Completed

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡